en

PRODUCT DETAIL

SYLVANT 400 mg prášok na infúzny koncentrát

Code 0680B
MA number EU/1/14/928/002
Product Form: plc ifc 1x400 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AC Interleukin inhibitors
L04AC11 Siltuximab
Shelf life: 48
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 22.05.2014
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 28.08.2023
eu-flag.png sk-flag.png